[{"symbol": "VRTX", "publishedDate": "2019-12-30 16:18:53", "title": "Jefferies: Less urgency to get legislation passed in 2020", "image": "https://cdn.snapi.dev/images/v1/m/q/jefferies-less-urgency-to-get-legislation-passed-in-2020.jpg", "site": "CNBC Television", "text": "Michael Yee, Jefferies analyst, discusses his outlook on biotech companies on CNBC's \"Closing Bell.\"", "url": "https://www.youtube.com/watch?v=c8TXPRvZzac"}, {"symbol": "VRTX", "publishedDate": "2019-12-30 10:40:00", "title": "5 Stocks to Buy in January", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5520292fa-rising-stack-of-coins-next-to-a-chart-of-yearsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "While the stock market is coming off its best year in more than two decades, we still see some good stocks to buy this January. Topping our list are a virtual search engine, biotech giant, Internet of Things (IoT) supplier, fitness company, and pipeline behemoth.", "url": "https://www.fool.com/investing/2019/12/30/5-stocks-to-buy-in-january.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-12-29 09:00:00", "title": "The 3 Best Healthcare Stocks to Buy for 2020", "image": "https://cdn.snapi.dev/images/v1/z/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5518912f2020-with-0s-formed-by-heart-and-a-stethoscopejpgw700opresize.jpg", "site": "The Motley Fool", "text": "These three healthcare stocks have all the ingredients needed to cook up great returns in the new year.", "url": "https://www.fool.com/investing/2019/12/29/the-3-best-healthcare-stocks-to-buy-for-2020.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-12-29 07:00:00", "title": "20 Great Stock Ideas For 2020, From The Best Fund Managers", "image": "https://cdn.snapi.dev/images/v1/p/u/20-great-stock-ideas-for-2020-from-the-best-fund-managers.jpg", "site": "Forbes", "text": "Top stock picks for 2020, according to the best portfolio managers.", "url": "https://www.forbes.com/sites/sergeiklebnikov/2020/12/29/20-great-stock-ideas-for-2020-from-the-best-fund-managers/"}, {"symbol": "VRTX", "publishedDate": "2019-12-27 16:43:57", "title": "Inphi And Vertex Flatten Out; Incyte Gets Support", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks2-4.jpg", "site": "Investors Business Daily", "text": "Markets Take A Pause; Stock Setups Continue.", "url": "https://www.youtube.com/watch?v=EeD1FvAQRg0"}, {"symbol": "VRTX", "publishedDate": "2019-12-19 10:18:00", "title": "Biotech Stock Outlook: M&A Activity Retains Growth Streak", "image": "https://cdn.snapi.dev/images/v1/w/o/biotech29.jpg", "site": "Zacks Investment Research", "text": "Biotech Stock Outlook: M&A Activity Retains Growth Streak", "url": "https://www.zacks.com/commentary/678203/biotech-stock-outlook-ma-activity-retains-growth-streak"}, {"symbol": "VRTX", "publishedDate": "2019-12-18 08:30:00", "title": "Better Buy:  Vertex Pharmaceuticals vs.  Alexion Pharmaceuticals", "image": "https://cdn.snapi.dev/images/v1/x/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5510712fgettyimages-1010214820jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Both of these drugmakers have solid portfolios and treatment pipelines, but savvy investors will find good reason to favor one over the other.", "url": "https://www.fool.com/investing/2019/12/18/better-buy-vertex-pharma-vs-alexion-pharma.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-12-17 18:27:37", "title": "8 Biotech Stocks Morgan Stanley Recommends For 2020", "image": "https://cdn.snapi.dev/images/v1/l/a/lab-217041-1280-2-6.jpg", "site": "Benzinga", "text": "Biotech investing is risk-fraught, but for\u00a0investors who make the right bets, the returns can be staggering.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/19/12/15004313/8-biotech-stocks-morgan-stanley-recommends-for-2020"}, {"symbol": "VRTX", "publishedDate": "2019-12-11 14:42:00", "title": "Vertex's Kalydeco Gets EU Approval to Treat CF in Infants", "image": "https://cdn.snapi.dev/images/v1/2/k/biotech9.jpg", "site": "Zacks Investment Research", "text": "Vertex's (VRTX) Kalydeco gains EU nod for use in infants with cystic fibrosis aged from six to less than 12 months with at least one of specified nine mutations in the CFTR gene.", "url": "https://www.zacks.com/stock/news/665846/vertexs-kalydeco-gets-eu-approval-to-treat-cf-in-infants"}, {"symbol": "VRTX", "publishedDate": "2019-12-11 12:45:03", "title": "Looking for a Growth Stock? 3 Reasons Why Vertex (VRTX) is a Solid Choice", "image": "https://cdn.snapi.dev/images/v1/h/k/biotech8.jpg", "site": "Zacks Investment Research", "text": "Vertex (VRTX) possesses solid growth attributes, which could help it handily outperform the market.", "url": "https://www.zacks.com/stock/news/665732/looking-for-a-growth-stock-3-reasons-why-vertex-vrtx-is-a-solid-choice"}, {"symbol": "VRTX", "publishedDate": "2019-12-10 08:09:00", "title": "5 Defensive Stocks to Buy as Volatility Index Soars", "image": "https://cdn.snapi.dev/images/v1/w/r/ee2d-2.jpg", "site": "Zacks Investment Research", "text": "On Dec 9, the fear gauge jumped 16% as uncertainties in the closure of U.S.-China trade deal instilled fear in investors.", "url": "https://www.zacks.com/stock/news/663610/5-defensive-stocks-to-buy-as-volatility-index-soars"}, {"symbol": "VRTX", "publishedDate": "2019-12-09 10:35:46", "title": "9 Most Overbought Stocks In The S&P 500", "image": "https://cdn.snapi.dev/images/v1/j/a/chart-1905225-1920-38.jpg", "site": "Benzinga", "text": "While value investors look for stocks that have become priced too low or high based on fundamental metrics such as earnings, revenue and debt, technical traders base their buys and sells off of recent trading action in a stock\u2019s charts.", "url": "https://www.benzinga.com/general/education/19/12/14954723/9-most-overbought-stocks-in-the-s-p-500"}, {"symbol": "VRTX", "publishedDate": "2019-12-08 14:00:00", "title": "3 Top Healthcare Stocks to Buy in December", "image": "https://cdn.snapi.dev/images/v1/o/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5500542fhealthcare-icons-with-doctor-holding-tabletjpgw700opresize.jpg", "site": "The Motley Fool", "text": "They dominate their respective markets. And they have fantastic growth prospects.", "url": "https://www.fool.com/investing/2019/12/08/3-top-healthcare-stocks-to-buy-in-december.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-12-06 07:00:00", "title": "Three Stocks from the Zacks #1 Rank Uptrends Screen", "image": "https://cdn.snapi.dev/images/v1/v/f/etf25-31.jpg", "site": "Zacks Investment Research", "text": "Three Stocks from the Zacks #1 Rank Uptrends Screen", "url": "https://www.zacks.com/commentary/656737/three-stocks-from-the-zacks-1-rank-uptrends-screen"}, {"symbol": "VRTX", "publishedDate": "2019-12-05 03:49:00", "title": "Gene Therapy the Next Best Thing: Here's Why (Revised)", "image": "https://cdn.snapi.dev/images/v1/a/k/biotech2.jpg", "site": "Zacks Investment Research", "text": "Recent activities like mergers and collaboration have boosted the gene therapy space this year, the broad and intriguing pipelines shows that the segment is poised to grow.", "url": "https://www.zacks.com/stock/news/655272/gene-therapy-the-next-best-thing-heres-why-revised"}, {"symbol": "VRTX", "publishedDate": "2019-12-04 09:42:00", "title": "Gene Therapy the Next Best Thing: Here's Why", "image": "https://cdn.snapi.dev/images/v1/7/3/biotech22.jpg", "site": "Zacks Investment Research", "text": "Recent activities like mergers and collaboration have boosted the gene therapy space this year, the broad and intriguing pipelines shows that the segment is poised to grow.", "url": "https://www.zacks.com/stock/news/654120/gene-therapy-the-next-best-thing-heres-why"}, {"symbol": "VRTX", "publishedDate": "2019-12-04 01:17:57", "title": "Here's Why Vertex Pharmaceuticals Rose 13.4% in November", "image": "https://cdn.snapi.dev/images/v1/t/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5498442fpaper-airplanes-risingjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The rare-disease specialist is putting together a respectable end-of-year run.", "url": "https://www.fool.com/investing/2019/12/04/heres-why-vertex-pharmaceuticals-rose-134-in-novem.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-12-03 09:00:46", "title": "Why You Should Keep An Eye On These 5 Leading Health Care Stocks", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech40.jpg", "site": "Investors Business Daily", "text": "The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.", "url": "https://www.investors.com/news/technology/health-care-stocks-buy-watch/"}, {"symbol": "VRTX", "publishedDate": "2019-12-02 11:00:28", "title": "Looking For Growth? Take A Look At These Biotechnology Stocks", "image": "https://cdn.snapi.dev/images/v1/0/9/092314-0028-nvsholdwith1.jpg", "site": "Investors Business Daily", "text": "The best biotech companies to invest in tend to have a commonality: a strong streak of earnings growth.\r\nThe post Looking For Growth?", "url": "https://www.investors.com/news/technology/biotech-stocks-best-biotech-companies-to-invest-in/"}, {"symbol": "VRTX", "publishedDate": "2019-12-01 07:30:00", "title": "3 Top Biotech Stocks to Buy in December", "image": "https://cdn.snapi.dev/images/v1/5/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5493772f3-test-tubes-2fommybjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These biotech stocks cover all the bases, from great dividends to promising pipelines.", "url": "https://www.fool.com/investing/2019/12/01/3-top-biotech-stocks-to-buy-in-december.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-11-29 09:24:00", "title": "5 New Drug Approvals the FDA Gave Top Priority", "image": "https://cdn.snapi.dev/images/v1/v/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5491932fman-holding-fda-blocks-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here's why the FDA recently approved five new drugs way ahead of schedule.", "url": "https://www.fool.com/investing/2019/11/29/5-new-drug-approvals-the-fda-gave-top-priority.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-11-27 12:32:20", "title": "Report: Vertex Railcar Owes Nearly $45.4 Million", "image": "https://cdn.snapi.dev/images/v1/x/t/rails-3309912-1920-82.jpg", "site": "Benzinga", "text": "FreightWaves occasionally posts high-quality content from partner publications in the freight industry.", "url": "https://www.benzinga.com/news/19/11/14896944/report-vertex-railcar-owes-nearly-45-4-million"}, {"symbol": "VRTX", "publishedDate": "2019-11-26 19:06:00", "title": "Why Biotech ETFs Surged in Monday's Trading Session", "image": "https://cdn.snapi.dev/images/v1/1/1/1149.jpg", "site": "Zacks Investment Research", "text": "Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to drive the biotech market.", "url": "https://www.zacks.com/stock/news/642212/why-biotech-etfs-surged-in-mondays-trading-session"}, {"symbol": "VRTX", "publishedDate": "2019-11-26 10:50:58", "title": "Vertex Pharma Shares Are Surging with Huge Demand", "image": "https://cdn.snapi.dev/images/v1/d/5/biotech35.jpg", "site": "Investopedia", "text": "Strong fundamentals alongside big money buy signals suggest additional upside potential for Vertex Pharmaceuticals stock.", "url": "https://www.investopedia.com/vertex-pharma-shares-are-surging-with-huge-demand-4777367"}, {"symbol": "VRTX", "publishedDate": "2019-11-26 06:07:00", "title": "4 Big Drug Stocks Ripe for Takeover After NVS-MDCO Deal", "image": "https://cdn.snapi.dev/images/v1/9/5/952.jpg", "site": "Zacks Investment Research", "text": "Here are four stocks that boast promising prospects and are most likely to be takeout targets.", "url": "https://www.zacks.com/stock/news/638202/4-big-drug-stocks-ripe-for-takeover-after-nvs-mdco-deal"}, {"symbol": "VRTX", "publishedDate": "2019-11-25 10:06:01", "title": "Biotech Stocks Awaken From Long Slumber", "image": "https://cdn.snapi.dev/images/v1/e/t/etf33.jpg", "site": "Investopedia", "text": "Biotech stocks have joined the fourth quarter rally and could post strong gains in the coming months.", "url": "https://www.investopedia.com/biotech-stocks-awaken-from-long-slumber-4777209"}, {"symbol": "VRTX", "publishedDate": "2019-11-24 09:00:00", "title": "3 Top Healthcare Stocks to Buy Now", "image": "https://cdn.snapi.dev/images/v1/5/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5487632fdoctor-with-stethescope-and-healthcare-imagesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These stocks are in the right place at the right time.", "url": "https://www.fool.com/investing/2019/11/24/3-top-healthcare-stocks-to-buy-now.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-11-21 10:24:00", "title": "Vertex (VRTX) Gets French Reimbursement for CF Drug Orkambi", "image": "https://cdn.snapi.dev/images/v1/x/x/biotech5.jpg", "site": "Zacks Investment Research", "text": "The French reimbursement for Vertex's (VRTX) cystic fibrosis medicine Orkambi removes a key overhang for the stock.", "url": "https://www.zacks.com/stock/news/631140/vertex-vrtx-gets-french-reimbursement-for-cf-drug-orkambi"}, {"symbol": "VRTX", "publishedDate": "2019-11-21 08:00:00", "title": "Vertex Pharmaceuticals Shares March Higher, Can It Continue?", "image": "https://cdn.snapi.dev/images/v1/s/g/biotech36.jpg", "site": "Zacks Investment Research", "text": "As of late, it has definitely been a great time to be an investor Vertex Pharmaceuticals.", "url": "https://www.zacks.com/stock/news/630743/vertex-pharmaceuticals-shares-march-higher-can-it-continue"}, {"symbol": "VRTX", "publishedDate": "2019-11-20 09:37:47", "title": "Check Out These 5 Fast-Growing Stocks to Buy", "image": "https://cdn.snapi.dev/images/v1/a/s/asset-management40.jpg", "site": "InvestorPlace", "text": "Growth is on a different track now, and here are some great ideas for stocks to buy to ride the momentum.", "url": "https://investorplace.com/2019/11/7-fast-growing-stocks-to-buy-today/"}, {"symbol": "VRTX", "publishedDate": "2019-11-20 09:12:00", "title": "Vertex, CRISPR's Gene Editing Drug Shows Positive Early Data", "image": "https://cdn.snapi.dev/images/v1/k/w/biotech15.jpg", "site": "Zacks Investment Research", "text": "Vertex (VRTX) and partner CRISPR Therapeutics announce positive early data from two studies on gene-editing drug CTX001 for the treatment of beta-thalassemia and sickle cell disease.", "url": "https://www.zacks.com/stock/news/629127/vertex-crisprs-gene-editing-drug-shows-positive-early-data"}, {"symbol": "VRTX", "publishedDate": "2019-11-19 10:14:00", "title": "4 Big Biotech Stocks Worth Considering Post Q3 Earnings", "image": "https://cdn.snapi.dev/images/v1/9/7/973.jpg", "site": "Zacks Investment Research", "text": "We highlight a few principal players from the biotech sector, which are likely to witness a winning run in the near term.", "url": "https://www.zacks.com/stock/news/627538/4-big-biotech-stocks-worth-considering-post-q3-earnings"}, {"symbol": "VRTX", "publishedDate": "2019-11-18 14:56:45", "title": "Vertex Pharmaceuticals Is A Strong Buy", "image": "https://cdn.snapi.dev/images/v1/q/x/biotech10.jpg", "site": "Seeking Alpha", "text": "Vertex Pharmaceuticals Is A Strong Buy", "url": "https://seekingalpha.com/article/4307551-vertex-pharmaceuticals-strong-buy"}, {"symbol": "VRTX", "publishedDate": "2019-11-18 10:00:00", "title": "Drug Approvals, Upbeat Earnings Help Vertex Pharmaceuticals\u2019 Stock Jump 20% In A Month", "image": "https://cdn.snapi.dev/images/v1/x/c/biotech3.jpg", "site": "Forbes", "text": "Vertex Pharmaceuticals (NASDAQ: VRTX) is an American biopharmaceutical company mainly focused on developing and commercializing therapies for the treatment of cystic fibrosis. Vertex has seen its stock price rise 15% over the last month, driven in part by the U.S.", "url": "https://www.forbes.com/sites/greatspeculations/2019/11/18/drug-approvals-upbeat-earnings-help-vertex-pharmaceuticals-stock-jump-20-in-a-month/"}, {"symbol": "VRTX", "publishedDate": "2019-11-18 07:00:00", "title": "Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants", "image": "https://cdn.snapi.dev/images/v1/b/s/press1.jpg", "site": "GlobeNewsWire", "text": "-Molecular Templates to receive $38 million upfront payment, including equity investment, with potential for additional milestone and royalty payments on future sales-", "url": "https://www.globenewswire.com/news-release/2019/11/18/1948581/0/en/Vertex-and-Molecular-Templates-Establish-Collaboration-to-Discover-and-Develop-Novel-Targeted-Conditioning-Regimens-to-Enhance-Hematopoietic-Stem-Cell-Transplants.html"}, {"symbol": "VRTX", "publishedDate": "2019-11-17 09:00:00", "title": "The Best Biotech Stock to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/l/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5477882fscientist-holding-test-tubejpgw700opresize.jpg", "site": "The Motley Fool", "text": "This biotech checks off all the boxes.", "url": "https://www.fool.com/investing/2019/11/17/the-best-biotech-stock-to-buy-right-now.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-11-15 10:20:04", "title": "Earnings Estimates Rising for Vertex (VRTX): Will It Gain?", "image": "https://cdn.snapi.dev/images/v1/d/x/biotech27.jpg", "site": "Zacks Investment Research", "text": "Vertex (VRTX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.", "url": "https://www.zacks.com/stock/news/621508/earnings-estimates-rising-for-vertex-vrtx-will-it-gain"}, {"symbol": "VRTX", "publishedDate": "2019-11-13 14:40:53", "title": "Join The Vertex Energy Journey", "image": "https://cdn.snapi.dev/images/v1/k/6/biotech3.jpg", "site": "Seeking Alpha", "text": "Join The Vertex Energy Journey", "url": "https://seekingalpha.com/article/4306281-join-vertex-energy-journey"}, {"symbol": "VRTX", "publishedDate": "2019-11-11 03:40:34", "title": "Vertex: A Crown Jewel Of Biotech", "image": "https://cdn.snapi.dev/images/v1/j/n/biotech40.jpg", "site": "Seeking Alpha", "text": "Vertex: A Crown Jewel Of Biotech", "url": "https://seekingalpha.com/article/4305310-vertex-crown-jewel-biotech"}, {"symbol": "VRTX", "publishedDate": "2019-11-10 07:00:00", "title": "3 Top Stocks to Buy in November", "image": "https://cdn.snapi.dev/images/v1/v/f/software21.jpg", "site": "The Motley Fool", "text": "They're leaders in their respective markets. And those markets are growing fast.", "url": "https://www.fool.com/investing/2019/11/10/3-top-stocks-to-buy-in-november.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-11-08 13:06:21", "title": "Vertex Energy, Inc. (VTNR) CEO Benjamin Cowart on Q3 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/x/c/transcript25.jpg", "site": "Seeking Alpha", "text": "Vertex Energy, Inc. (VTNR) CEO Benjamin Cowart on Q3 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4304484-vertex-energy-inc-vtnr-ceo-benjamin-cowart-q3-2019-results-earnings-call-transcript"}, {"symbol": "VRTX", "publishedDate": "2019-11-08 08:34:00", "title": "Moving Average Crossover Alert: Vertex Pharmaceuticals", "image": "https://cdn.snapi.dev/images/v1/b/k/biotech20.jpg", "site": "Zacks Investment Research", "text": "Vertex Pharmaceuticals is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.", "url": "https://www.zacks.com/stock/news/610009/moving-average-crossover-alert-vertex-pharmaceuticals"}, {"symbol": "VRTX", "publishedDate": "2019-11-06 10:07:29", "title": "Why the Opioid Crisis Makes Vertex Pharmaceuticals a Buy", "image": "https://cdn.snapi.dev/images/v1/h/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5462122fgettyimages-1013497338jpgw700opresize.jpg", "site": "The Motley Fool", "text": "This biotech stock gives investors upside to cutting-edge non-opioid pain management with a trusty revenue stream from its legacy suite of treatments for cystic fibrosis.", "url": "https://www.fool.com/investing/2019/11/06/why-the-opioid-crisis-makes-vertex-pharmaceuticals.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-10-31 12:33:00", "title": "Vertex (VRTX) Q3 Earnings Beat, Revenues Lag Estimates", "image": "https://cdn.snapi.dev/images/v1/o/l/biotech5.jpg", "site": "Zacks Investment Research", "text": "Vertex (VRTX) encourages investors with better-than-expected earnings in Q3. However, the top line misses the mark.", "url": "https://www.zacks.com/stock/news/596693/vertex-vrtx-q3-earnings-beat-revenues-lag-estimates"}, {"symbol": "VRTX", "publishedDate": "2019-10-31 10:09:16", "title": "Vertex Pharmaceuticals Posts Strong 3rd-Quarter Revenue Growth", "image": "https://cdn.snapi.dev/images/v1/o/b/biotech13.jpg", "site": "GuruFocus", "text": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) issued its third quarter results after the closing bell on Wednesday.", "url": "https://www.gurufocus.com/news/973374/vertex-pharmaceuticals-posts-strong-3rdquarter-revenue-growth-"}, {"symbol": "VRTX", "publishedDate": "2019-10-31 08:59:00", "title": "2 Top Healthcare Stocks Every Investor Should Own", "image": "https://cdn.snapi.dev/images/v1/l/t/hea2.jpg", "site": "The Motley Fool", "text": "These titans of the healthcare sector sport virtual monopolies in their core markets.", "url": "https://www.fool.com/investing/2019/10/31/2-top-healthcare-stocks-every-investor-should-own.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-10-31 07:07:00", "title": "Will Vertex Pharmaceuticals Continue to Surge Higher?", "image": "https://cdn.snapi.dev/images/v1/f/d/biotech9.jpg", "site": "Zacks Investment Research", "text": "As of late, it has definitely been a great time to be an investor Vertex Pharmaceuticals.", "url": "https://www.zacks.com/stock/news/594788/will-vertex-pharmaceuticals-continue-to-surge-higher"}, {"symbol": "VRTX", "publishedDate": "2019-10-30 23:43:08", "title": "Vertex Pharmaceuticals Incorporated (VRTX) CEO Jeff Leiden on Q3 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/j/r/transcript12.jpg", "site": "Seeking Alpha", "text": "Vertex Pharmaceuticals Incorporated (VRTX) CEO Jeff Leiden on Q3 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4300728-vertex-pharmaceuticals-incorporated-vrtx-ceo-jeff-leiden-q3-2019-results-earnings-call"}, {"symbol": "VRTX", "publishedDate": "2019-10-30 17:15:03", "title": "Vertex Pharmaceuticals (VRTX) Beats Q3 Earnings Estimates", "image": "https://cdn.snapi.dev/images/v1/x/l/biotech35.jpg", "site": "Zacks Investment Research", "text": "Vertex (VRTX) delivered earnings and revenue surprises of 7.89% and -0.25%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/593902/vertex-pharmaceuticals-vrtx-beats-q3-earnings-estimates"}, {"symbol": "VRTX", "publishedDate": "2019-10-30 16:14:48", "title": "The Top-Rated Biotech Stock Just Reported A Mixed Third Quarter", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech40.jpg", "site": "Investors Business Daily", "text": "Vertex earnings of $1.23 per share, minus some items, beat estimates Wednesday. But $949.8 million in sales lagged narrowly.", "url": "https://www.investors.com/news/technology/vertex-stock-vertex-earnings-q3-2019/"}, {"symbol": "VRTX", "publishedDate": "2019-10-29 10:32:56", "title": "Vertex Energy (VTNR) to Report Q3 Results: Wall Street Expects Earnings Growth", "image": "https://cdn.snapi.dev/images/v1/z/5/biotech16.jpg", "site": "Zacks Investment Research", "text": "Vertex Energy (VTNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/590631/vertex-energy-vtnr-to-report-q3-results-wall-street-expects-earnings-growth"}, {"symbol": "VRTX", "publishedDate": "2019-10-29 09:28:00", "title": "Looking for an Earnings Beat? 5 Top Picks", "image": "https://cdn.snapi.dev/images/v1/6/5/software31.jpg", "site": "Zacks Investment Research", "text": "5 top-ranked stocks likely to beat on earnings are great investment picks for stellar gains.", "url": "https://www.zacks.com/stock/news/590387/looking-for-an-earnings-beat-5-top-picks"}, {"symbol": "VRTX", "publishedDate": "2019-10-28 10:45:44", "title": "Vertex Pharmaceuticals Gains FDA Approval for Cystic Fibrosis Drug", "image": "https://cdn.snapi.dev/images/v1/o/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5435282fgettyimages-1137042463jpgw700opresize.jpg", "site": "The Motley Fool", "text": "What should investors think of this piece of news?", "url": "https://www.fool.com/investing/2019/10/28/vertex-pharmaceuticals-gains-fda-approval-for-cyst.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-10-26 08:00:06", "title": "Google, Facebook, AMD Lead 5 Large-Cap Stocks Near Buy Points With Earnings Due", "image": "https://cdn.snapi.dev/images/v1/2/3/23insdp-1.jpg", "site": "Investors Business Daily", "text": "Google, Facebook, AMD, Mastercard and Vertex Pharmaceuticals are large caps near buy points. All five have earnings this coming week.", "url": "https://www.investors.com/news/google-stock-facebook-stock-amd-stock-near-buy-points/"}, {"symbol": "VRTX", "publishedDate": "2019-10-25 12:06:00", "title": "Can CF Drugs Drive Growth for Vertex (VRTX) in Q3 Earnings?", "image": "https://cdn.snapi.dev/images/v1/j/e/biotech18.jpg", "site": "Zacks Investment Research", "text": "During Vertex's (VRTX) third-quarter earnings call, investor focus will be on the uptake of its newest CF drug Symdeko and the update on the recent approval of Trikafta triple combination regimen.", "url": "https://www.zacks.com/stock/news/584435/can-cf-drugs-drive-growth-for-vertex-vrtx-in-q3-earnings"}, {"symbol": "VRTX", "publishedDate": "2019-10-25 09:21:00", "title": "Top Ranked Momentum Stocks to Buy for October 25th", "image": "https://cdn.snapi.dev/images/v1/a/s/asset-management35.jpg", "site": "Zacks Investment Research", "text": "Top Ranked Momentum Stocks to Buy for October 25th", "url": "https://www.zacks.com/commentary/583858/top-ranked-momentum-stocks-to-buy-for-october-25th"}, {"symbol": "VRTX", "publishedDate": "2019-10-25 07:47:00", "title": "5 Top Volatility-Defying S&P 500 Stocks of Past Month", "image": "https://cdn.snapi.dev/images/v1/t/x/etf35-8.jpg", "site": "Zacks Investment Research", "text": "Year to date, the benchmark S&P 500 Index has rallied 20.1%, an impressive performance after a disappointing 2018, when it lost 6.6%.", "url": "https://www.zacks.com/stock/news/583800/5-top-volatility-defying-sp-500-stocks-of-past-month"}, {"symbol": "VRTX", "publishedDate": "2019-10-25 07:00:00", "title": "2 Things Just Happened That Make Vertex Pharmaceuticals Stock a Screaming Buy", "image": "https://cdn.snapi.dev/images/v1/y/p/biotechmsn.jpg", "site": "The Motley Fool", "text": "It's been a big week for this fast-growing biotech.", "url": "https://www.fool.com/investing/2019/10/25/2-things-just-happened-that-make-vertex-pharmaceut.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-10-24 10:50:00", "title": "5 Drug/Biotech Stocks Likely to Surpass on Earnings in Q3", "image": "https://cdn.snapi.dev/images/v1/e/a/drugs6.jpg", "site": "Zacks Investment Research", "text": "Let us take a look at some drug/biotech stocks that are poised to beat on earnings in the third quarter.", "url": "https://www.zacks.com/stock/news/582314/5-drug-biotech-stocks-likely-to-surpass-on-earnings-in-q3"}, {"symbol": "VRTX", "publishedDate": "2019-10-22 16:39:58", "title": "Medicals Lead, Growth Hurt: New Oriental, Visa, United Tech, Vertex", "image": "https://cdn.snapi.dev/images/v1/v/b/stock-exchange-1376107-960-720-136.jpeg", "site": "Investors Business Daily", "text": "Medicals lead, growth stocks hurt: New Oriental, Visa, United Tech, Vertex move.", "url": "https://www.youtube.com/watch?v=B71tZyk-Z1A"}, {"symbol": "VRTX", "publishedDate": "2019-10-22 13:23:57", "title": "5 Healthcare Stocks to Buy", "image": "https://cdn.snapi.dev/images/v1/h/e/healthcare1600a-768x432.jpg", "site": "InvestorPlace", "text": "Healthcare in particular is one such sector, with a number of large-cap biotechnology and pharmaceutical stocks enjoying fresh rallies.", "url": "https://investorplace.com/2019/10/5-healthcare-stocks-to-buy-2/"}, {"symbol": "VRTX", "publishedDate": "2019-10-22 10:56:28", "title": "Vertex Shares Are Rallying: What You Need To Know", "image": "https://cdn.snapi.dev/images/v1/5/v/anatomical-2261006-1920-12.jpg", "site": "Benzinga", "text": "Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares were off\u00a0to a flying start Tuesday, extending the late-session surge from Monday that followed\u00a0a positive FDA verdict.", "url": "https://www.benzinga.com/general/biotech/19/10/14636557/vertex-shares-are-rallying-what-you-need-to-know"}, {"symbol": "VRTX", "publishedDate": "2019-10-22 09:49:35", "title": "Vertex Stock Jumps After Highly Anticipated CF Drug Gains Approval", "image": "https://cdn.snapi.dev/images/v1/5/i/biotech15.jpg", "site": "Investors Business Daily", "text": "Shares of Vertex Pharmaceuticals jumped in higher-than-average volume early Tuesday after the biotech company gained FDA approval for a highly anticipated cystic fibrosis treatment.\nThe post Vertex Stock Jumps After Highly Anticipated CF Drug Gains Approval appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/vertex-stock-jumps-biotech-company-fda-nod-cystic-fibrosis-treatment/"}, {"symbol": "VRTX", "publishedDate": "2019-10-21 07:56:00", "title": "5 Large-Cap Stocks Set to Beat Earnings Estimates This Month", "image": "https://cdn.snapi.dev/images/v1/3/6/363.jpg", "site": "Zacks Investment Research", "text": "Third-quarter 2019 earnings results so far are not as disappointing as expected initially. However, the forecast of overall earnings dip in the third quarter is still looming large.", "url": "https://www.zacks.com/stock/news/575128/5-large-cap-stocks-set-to-beat-earnings-estimates-this-month"}, {"symbol": "VRTX", "publishedDate": "2019-10-17 10:24:00", "title": "2 High-Growth Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/x/7/ees23.jpg", "site": "The Motley Fool", "text": "BioMarin Pharmaceutical and Vertex Pharmaceuticals should prove to be outstanding growth vehicles in 2020 and beyond.", "url": "https://www.fool.com/investing/2019/10/17/2-high-growth-stocks-to-buy-right-now.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-10-16 10:33:00", "title": "Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?", "image": "https://cdn.snapi.dev/images/v1/j/g/biotech11.jpg", "site": "Zacks Investment Research", "text": "Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/567556/vertex-pharmaceuticals-vrtx-earnings-expected-to-grow-should-you-buy"}, {"symbol": "VRTX", "publishedDate": "2019-10-14 10:10:22", "title": "Can Vertex (VRTX) Keep the Earnings Surprise Streak Alive?", "image": "https://cdn.snapi.dev/images/v1/m/c/biotech21.jpg", "site": "Zacks Investment Research", "text": "Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.", "url": "https://www.zacks.com/stock/news/563648/can-vertex-vrtx-keep-the-earnings-surprise-streak-alive"}, {"symbol": "VRTX", "publishedDate": "2019-10-08 13:55:32", "title": "5 Large-Cap Stocks With Growth in the Tank", "image": "https://cdn.snapi.dev/images/v1/c/a/cahs82-1.jpg", "site": "InvestorPlace", "text": "Investors looking for the safety of large-cap stocks alongside impressive growth should consider these five investments.", "url": "https://investorplace.com/2019/10/5-large-cap-stocks-with-growth-in-the-tank/"}, {"symbol": "VRTX", "publishedDate": "2019-10-08 07:00:00", "title": "3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year", "image": "https://cdn.snapi.dev/images/v1/s/r/vert2.jpg", "site": "The Motley Fool", "text": "The market has yet to recognize Vertex's accelerating cash flow and growing future prospects.", "url": "https://www.fool.com/investing/2019/10/08/3-reasons-vertex-pharmaceuticals-is-poised-for-a-b.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-10-02 09:29:00", "title": "Vertex Enters Into Collaboration With Privately-Held Ribometrix", "image": "https://cdn.snapi.dev/images/v1/m/y/biotech33.jpg", "site": "Zacks Investment Research", "text": "Vertex (VRTX) inks collaboration agreement with privately-held biotech, Ribometrix, for developing up to three RNA-targeted treatments for serious diseases.", "url": "https://www.zacks.com/stock/news/545835/vertex-enters-into-collaboration-with-privately-held-ribometrix"}, {"symbol": "VRTX", "publishedDate": "2019-10-02 08:00:00", "title": "Forget Vertex Pharmaceuticals; CRISPR Therapeutics Is a Better Biotech Growth Stock", "image": "https://cdn.snapi.dev/images/v1/v/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5409982fgettyimages-1140779660jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Despite working together on a major project, these two biotech stocks couldn't be more different from a growth perspective.", "url": "https://www.fool.com/investing/2019/10/02/forget-vertex-pharmaceuticals-crispr-therapeutics.aspx"}, {"symbol": "VRTX", "publishedDate": "2019-10-01 06:00:00", "title": "3  Top Biotech Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/4/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5410062ffemale-scientist-holding-2-test-tubesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These biotech stocks are great picks -- but for very different reasons.", "url": "https://www.fool.com/investing/2019/10/01/3-top-biotech-stocks-to-buy-right-now.aspx"}]